A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: a trial of the Princess Margaret, Chicago and California Phase II Consortia (Q43902249)
Jump to navigation
Jump to search
scientific article published on 17 April 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: a trial of the Princess Margaret, Chicago and California Phase II Consortia |
scientific article published on 17 April 2015 |
Statements
1 reference
A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: a trial of the Princess Margaret, Chicago and California Phase II Consortia (English)
1 reference
H Hirte
1 reference
S Lheureux
1 reference
G F Fleming
1 reference
A Sugimoto
1 reference
R Morgan
1 reference
J Biagi
1 reference
L Wang
1 reference
S McGill
1 reference
S P Ivy
1 reference
A M Oza
1 reference
17 April 2015
1 reference
1 reference
138
1 reference
1
1 reference
55-61
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference